companydata.dkcompanydata.dk

POLYPEPTIDE LABORATORIES A/S: Financial statements 2018

CVR: 19056201

Source: annual report 2018, Danish Business Authority

01/01/201831/12/2018

POLYPEPTIDE LABORATORIES A/S (CVR 19056201) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 0 and a net result of DKK -1,482,000 compared with DKK -757,000 the year before. Equity in the 2018 report amounted to DKK 66,000,000. The solvency ratio was 99.9%.

Profit/Loss
DKK -1,482,000
Equity
DKK 66,000,000
Total Assets
DKK 66,035,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-0-1.5 mio.66 mio.-
2017-721 t.-757 t.67.5 mio.0
2016-15.2 mio.-3.3 mio.68.2 mio.12000
2015---9.5 mio.64.9 mio.31
2014-36.6 mio.17.1 mio.74.4 mio.26

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

POLYPEPTIDE LABORATORIES A/S: The 2017 annual report is outApr 12, 2018

POLYPEPTIDE LABORATORIES A/S has published its annual report for 2017. Gross profit came to DKK 721,000, and the net result was DKK -757,000.

About POLYPEPTIDE LABORATORIES A/S

POLYPEPTIDE LABORATORIES A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 1996. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named A/S PSE NR. 4948. The management consists of Raoul Bernhardt. The board consists of Juan José Gonzalez Casanova (chair), Christina Ellen Del Vecchio and Raoul Bernhardt. The company is owned by PolyPeptide Laboratories Holding (PPL) AB. The company has 0 employees (2017). In 2025, the company reported a net result of DKK 2,632,000 compared with DKK 7,060,000 the year before. Equity in the 2025 report amounted to DKK 75,499,000.

Source: annual report 2025, Danish Business Authority